Splicing mutations - Melissa Moore (U Mass/HHMI)

TL;DR

Splicing mutations significantly contribute to human genetic diseases.

Transcript

so one thing I'd like to point out about these splicing enhancer and silencer sequences is that mutations in those sequences can lead to human genetic disease so about 20% of human genetic disease is caused by mistakes in splicing and these mistakes can occur if a mutation occurs at one of the consensus sequences we've already seen that for the bet... Read More

Key Insights

• Mutations in splicing enhancer and silencer sequences can lead to human genetic diseases, affecting about 20% of such conditions.
• Common errors in identifying disease-causing mutations include assuming changes in coding exons only alter amino acids, ignoring potential splicing pattern changes.
• Mutations in introns, not just exons, can influence splicing, necessitating sequencing of both when investigating genetic disorders.
• The SMN gene example illustrates how mutations can disrupt splicing, leading to spinal muscular atrophy due to insufficient SMN protein production.
• A nonsense mutation in the DREN gene can create a splicing silencer, leading to exon exclusion and altered protein production.
• Frontal temporal dementia can result from mutations in the TAL gene, affecting the balance of protein forms through altered splicing.
• Eukaryotic genes often contain introns, facilitating gene evolution and increasing proteome complexity through alternative splicing.
• Many hereditary disorders arise from mutations affecting exon inclusion or splice site choice, highlighting the importance of understanding splicing mechanisms.

Questions & Answers

Q: What role do splicing mutations play in genetic diseases?

Splicing mutations significantly contribute to genetic diseases by altering the normal splicing patterns of genes. These mutations can occur in splicing enhancer or silencer sequences, leading to incorrect exon inclusion or exclusion. This results in the production of dysfunctional proteins, which can cause various genetic disorders.

Q: Why is it important to consider intronic mutations in genetic analysis?

Intronic mutations are important in genetic analysis because they can affect splicing patterns, similar to mutations in exons. Mutations in intronic splicing enhancers or silencers can lead to exon skipping or incorrect splice site selection, impacting protein function and contributing to genetic diseases. Thus, both exons and introns should be sequenced when investigating genetic disorders.

Q: How does the SMN gene mutation lead to spinal muscular atrophy?

The SMN gene mutation leads to spinal muscular atrophy by disrupting the normal splicing of the gene. The SMN1 gene, when mutated, fails to produce enough SMN protein. The SMN2 gene, which could compensate, has a mutation in an exonic splicing enhancer that results in reduced inclusion of exon 7, further decreasing SMN protein levels and causing the disease.

Q: What is the impact of a nonsense mutation in the DREN gene?

A nonsense mutation in the DREN gene can create an exonic splicing silencer, leading to the exclusion of the affected exon from the mRNA. This results in the production of a protein lacking that exon, potentially altering its function and contributing to disease. This illustrates how splicing mutations can have significant effects beyond amino acid changes.

Q: How does the TAL gene mutation contribute to frontal temporal dementia?

The TAL gene mutation contributes to frontal temporal dementia by enhancing an exonic splicing enhancer, leading to an imbalance in the production of different protein forms. This mutation causes more of the protein variant with exon 10 included, disrupting the normal 50/50 ratio necessary for healthy tau protein function, which is critical in preventing neurodegenerative conditions like dementia.

Q: What is the significance of introns in eukaryotic genes?

Introns in eukaryotic genes are significant because they facilitate the evolution of new genes and increase proteome complexity through alternative splicing. By allowing different combinations of exons to be included in mRNA, introns contribute to the diversity of proteins that a single gene can produce, enhancing the organism's adaptability and functionality.

Q: Why is alternative splicing important in gene expression?

Alternative splicing is important in gene expression because it allows a single gene to produce multiple protein variants, increasing the diversity of proteins and their functions within an organism. This process enables cells to adapt to different conditions and perform various functions, contributing to the complexity and versatility of higher organisms' proteomes.

Q: What are the challenges in identifying mutations that cause genetic disorders?

Identifying mutations that cause genetic disorders is challenging because mutations can occur in both exons and introns, affecting splicing patterns. Researchers must consider not only coding sequences but also splicing enhancers and silencers. Additionally, distinguishing between mutations that alter protein structure versus those that affect splicing requires thorough genetic analysis and understanding of splicing mechanisms.

Summary & Key Takeaways

• Mutations in splicing sequences, including enhancers and silencers, are responsible for a significant portion of human genetic diseases. These mutations can alter splicing patterns, leading to incorrect protein production and various disorders. Understanding these mechanisms is crucial for identifying disease-causing mutations.

• Examples such as the SMN, DREN, and TAL genes demonstrate how mutations impact splicing and contribute to diseases like spinal muscular atrophy and frontal temporal dementia. These cases emphasize the need to consider splicing changes when diagnosing genetic disorders.

• Eukaryotic genes contain introns that facilitate gene evolution and proteome complexity. Splicing is a critical process in gene expression, and mutations affecting splicing can have severe hereditary consequences, underscoring the need for comprehensive genetic analysis.